Clinical trial
Study to Treat Uveitis Associated Macular Edema
NCT00114062 · Merck Sharp & Dohme LLC, Industry · Terminated
Key facts
| NCT number | NCT00114062 |
|---|---|
| Title | Study to Treat Uveitis Associated Macular Edema |
| Official title | A Randomized, Double-Masked, Parallel Group, Multi-Center, Dose Ranging Pilot Study of Denufosol Tetrasodium (INS37217) Intravitreal Injection in Subjects With Uveitis Associated Macular Edema |
| Lead sponsor | Merck Sharp & Dohme LLC, Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Cystoid Macular Edema, Uveitis |
| Intervention type | Drug |
| Interventions | denufosol tetrasodium (INS37217) Intravitreal Injection |
| Enrollment | 15 |
| Start date | Sep 1, 2005 |
| Primary completion | Dec 1, 2006 |
| Completion | Dec 1, 2006 |
| First posted | Jun 14, 2005 |
| Last update posted | Nov 29, 2016 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: